ReviewAdvanced drug delivery reviews2026
Optical imaging and spectroscopic characterization of subvisible particles in protein therapeutics.
Review in Advanced drug delivery reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The presence of subvisible particles in protein-based pharmaceutics is a critical quality attribute that is highly regulated due to potential risks to product stability, quality, bioavailability, and patient safety. While numerous analytical technologies have been developed to measure and analyze these particles, optical characterization methods are widely used for their simplicity, robustness, and versatility. Selecting the appropriate technique from a vast array of optical spectroscopy and imaging methods can be overwhelming, but it is crucial for successful characterization. For example, compendial methods such as light obscuration are most commonly used but can underestimate particle counts and are unable to provide chemical identification. This review article aims to provide a comprehensive comparison of optical particle characterization techniques, detailing their physical principles, applications, strengths, and weaknesses. We evaluate methods based on elastic light scattering, flow-based imaging, particle tracking, and vibrational spectroscopy. We highlight the inherent trade-off between analytical throughput and information content, aiming to guide the rational selection of analytical tools for the comprehensive characterization of subvisible particles in protein therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.